Otoconial repositioning alters brain connectivity in benign paroxysmal positional vertigo patients.
This cohort study examined patients with benign paroxysmal positional vertigo (BPPV) and healthy controls. The population consisted of 29 BPPV patients and 29 healthy controls. The intervention involved otoconial repositioning treatment, with healthy controls and pre-treatment baseline serving as comparators. The primary outcomes assessed were whole-brain functional connectivity (FC) and Dizziness Handicap Inventory (DHI) scores, with follow-up conducted 7 days after repositioning.
Before treatment, whole-brain FC was significantly lower in the BPPV group compared to the control group. The absolute values were 0.52 ± 0.20 for the BPPV group and 0.64 ± 0.18 for the control group, with a t-statistic of -4.32 and a P value less than 0.01. Following repositioning, FC in the visual cortex (V1, V2, V3) and somatosensory cortex increased relative to pre-treatment levels (P < 0.05). However, these values did not return to normal levels when compared to the control group (P < 0.05).
A negative correlation was observed between DHI scores and whole-brain FC (r = -0.62; P < 0.01). Safety data, including adverse events and tolerability, were not reported. The study findings support the development of neuroregulation-assisted therapy but are limited by the observational cohort design and lack of reported funding or conflicts of interest.